Data collection of the patients receiving Vivitra® (Observational i.e. Non interventional)
Not Applicable
- Conditions
- Health Condition 1: null- 1. Metastatic breast cancer2. Metastatic Gastric Cancer3. Early Breast Cancer
- Registration Number
- CTRI/2018/05/013754
- Lead Sponsor
- Cadila Healthcare Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient should have completed the 4 cycle of VivitraTM treatment on the approved indications
Exclusion Criteria
Any reason which may prevent the doctor to enroll the patient in the registry.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Current status of the patients <br/ ><br>2 Patient/Doctor assessment of therapy <br/ ><br>3 Patient compliance <br/ ><br>4 Quality of lifeTimepoint: After 18 Months from the study start
- Secondary Outcome Measures
Name Time Method ATimepoint: NA